TopSpin Medical Inc.
This article was originally published in Start Up
Several start-up companies are investigating a variety of new technologies to identify vulnerable plaque using, for example thermography, infrared, and optical coherence tomography. But the founder of TopSpin Medical believed that a technology already existed with the capability of differentiating lipid-rich from fibrotic tissue: magnetic resonance imaging. TopSpin has developed a system that creates a local magnetic field-inside a patient with a catheter-and creates an MR image. What's more, having the catheter close to the target tissue eliminates the motion artifacts that conventional external MRI systems experience when imaging pulsating coronary arteries.
You may also be interested in...
Among imaging modalities used to guide surgery, magnetic resonance imaging (MRI) is growing at the fastest rate. According to “"US Markets for Imaged-Guided Surgery Products,"” published in November 2007 by Medtech Insight, MRI systems used in surgery or interventional procedures accounted for 12.5% of the $1.24 billion in surgical interventional imaging sales in the US in 2006, and procedure volumes are expected to grow at a compound annual rate of 9.2% through the year 2011. While it's obvious that the diagnostic imaging giants are positioned to enjoy the growth in emerging applications of MRI, start-ups can profit too.
In terms of medical applications magnetic resonance imaging could serve, the modality is still underused, and that means a large, untapped growth opportunity for the entrenched large manufacturers that dominate the industry with an installed base of capital equipment. Small companies have a role to play as well, with adjunctive technologies that serve the large players, or in niches too small for the multi-billion dollar players to notice.
Guidant appears to be the leader among the large cardiovascular device companies in pursuing device-based therapies for vulnerable plaque. The company's latest move in this space is a collaboration with Miravant Medical Technologies regarding using photodynamic therapy as a possible treatment for vulnerable plaque lesions.